Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Steve Sison"'
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 22(7)
To characterize workplace productivity measures in patients with metastatic breast cancer (mBC) using line of therapy (LOT) and first line (1 L) regimen. A retrospective cohort study was conducted using IBM’s MarketScan Commercial Claims and Encoun
Publikováno v:
Research in Social and Administrative Pharmacy. 14:434-440
Background Lost productivity in the workplace represents a significant portion of the economic burden of cancer in the United States. Cancer treatments have historically been physician-administered, while recent innovations have led to the developmen
Autor:
Seanna Vine, Joanna P. MacEwan, Katharine Batt, Desi Peneva, Steve Sison, Wes Yin, Clara Chen
Publikováno v:
Leukemia & Lymphoma. 59:941-949
This study characterized the costs of multiple myeloma (MM) during first-line (1L), second-line (2L) and third-line (3L) treatment from the US payer perspective. Patients with ≥2 outpatient or ≥1 inpatient claims with a primary MM diagnosis and 1
Autor:
Julia J Perkins, Greg Smith, Wesley Yin, Yanyu Wu, Steve Sison, Tomas Philipson, Julia Thornton Snider, Ruslan Horblyuk
Publikováno v:
Journal of Occupational & Environmental Medicine. 59:198-204
OBJECTIVE Determine workplace productivity losses attributable to breast cancer progression. METHODS Longitudinal analysis linking 2005 to 2012 medical and pharmacy claims and workplace absence data in the US patients were commercially insured women
Publikováno v:
Gerontology. 44:40-45
The aim of this investigation was to develop an inexpensive, efficient system for the clinical assessment of static and dynamic balance and postural sway using accelerometry-based measurements. Subjects consisted of 10 young (range 18–32 years) and
Autor:
Seanna Vine, Wes Yin, Manan Shah, Joanna P. MacEwan, Katharine Batt, Clara Chen, Steve Sison, Desi Peneva
Publikováno v:
Blood. 126:2100-2100
Background: The substantial improvement in clinical outcomes for patients with multiple myeloma (MM) conferred by proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), and bisphosphonates is associated with an increased financial burden on the
Autor:
Manan Shah, Seanna Vine, Katharine Batt, Clara Chen, Wes Yin, Desi Peneva, Joanna P. MacEwan, Steve Sison
Publikováno v:
Blood. 126:2116-2116
Background: Since 2005, treatment (TX) for patients with multiple myeloma (MM) has been revolutionized by the introduction of new agents that have demonstrated improved clinical outcomes. However, growing constraints on healthcare resources make it i
Autor:
Ruslan Horblyuk, Gregory Smith, Steve Sison, Julia J Perkins, Julia Thornton Snider, Tomas Philipson, Wesley Yin, Yanyu Wu
Publikováno v:
Journal of Clinical Oncology. 33:6586-6586
6586 Background: A significant fraction of women with breast cancer leave employment due to their disease. However, little is known about the effects of breast cancer progression on productivity am...
Publikováno v:
Journal of applied physiology (Bethesda, Md. : 1985). 79(6)
A reduction in maximal force production is a common observation in older individuals. In an effort to determine whether aging is accompanied by reductions in central motoneuron drive limiting motor performance, motor unit discharge records were obtai
Publikováno v:
Journal of Allergy and Clinical Immunology. 117:S265